Compare CWAN & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CWAN | MASI |
|---|---|---|
| Founded | 2004 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.6B |
| IPO Year | 2021 | 2007 |
| Metric | CWAN | MASI |
|---|---|---|
| Price | $24.13 | $127.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $29.12 | ★ $188.80 |
| AVG Volume (30 Days) | ★ 13.0M | 759.8K |
| Earning Date | 02-18-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46826.67 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | $640,376,000.00 | ★ $2,182,000,000.00 |
| Revenue This Year | $64.93 | N/A |
| Revenue Next Year | $29.40 | $6.83 |
| P/E Ratio | $17.21 | ★ N/A |
| Revenue Growth | ★ 50.91 | 38.48 |
| 52 Week Low | $15.74 | $126.57 |
| 52 Week High | $32.00 | $194.88 |
| Indicator | CWAN | MASI |
|---|---|---|
| Relative Strength Index (RSI) | 72.83 | 31.93 |
| Support Level | $24.05 | $131.47 |
| Resistance Level | $24.28 | $131.95 |
| Average True Range (ATR) | 0.36 | 3.12 |
| MACD | 0.08 | -0.59 |
| Stochastic Oscillator | 94.90 | 6.85 |
Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.